...
首页> 外文期刊>Iranian Journal of Pharmaceutical Research >Facile Synthesis and Characterization of Ibuprofen-mesoporous Hydroxyapatite Nanohybrid as a Sustained Drug Delivery System
【24h】

Facile Synthesis and Characterization of Ibuprofen-mesoporous Hydroxyapatite Nanohybrid as a Sustained Drug Delivery System

机译:布洛芬-中孔羟基磷灰石纳米杂化物作为持续药物输送系统的简便合成与表征

获取原文
   

获取外文期刊封面封底 >>

       

摘要

The present study deals with the fabrication of ibuprofen-mesoporous hydroxyapatite (IBU-MHA) particles via the incorporation of ibuprofen (IBU)a??as a nonsteroidal anti-inflammatory druga??into mesoporous hydroxyapatite nanoparticles (MHANPs) using an impregnation process, as a novel drug delivery device. MHANPs were synthesized by a self-assembly process using cetyltrimethylammonium bromide (CTAB) as a cationic surfactant and 1-dodecanethiol as a pore expander under basic condition. The focus of the present study was to optimize the incorporation of IBU molecules into MHANPs under different loading conditions. The synthesized MHANPs and IBU-MHA particles were confirmed by X-ray diffraction (XRD), fourier-transform infrared spectroscopy (FTIR), brunauera??emmetta??teller (BET), transmission electron microscopy (TEM), and thermal analysis (TGA). Drug loading (DL) efficiency of IBU-MHA particles was determined by ultravioleta??visible (UV-Vis) spectroscopy, and indicated that the optimized IBU-MHA particles with high DL (34.5%) can be obtained at an IBU/ MHANPs ratio of 35/50 (mg/mg), impregnation period of 24 h, and temperature of 40 ?°C using ethanol as solvent. In-vitro drug release test was carried out to prove the efficiency of IBU-MHA particles as a sustained drug delivery system. A more sustained and controlled drug release was observed for this particles, indicating that it may be have good potential as drug reservoirs for local drug release. ??
机译:本研究旨在通过采用浸渍工艺将布洛芬(IBU)a作为非甾体类抗炎药,将布洛芬(IBU)a?作为非甾体类抗炎药,掺入中孔羟基磷灰石纳米颗粒(MHANPs)中,作为一种新型的药物输送装置。在基本条件下,使用十六烷基三甲基溴化铵(CTAB)作为阳离子表面活性剂和1-十二烷硫醇作为扩孔剂,通过自组装工艺合成了MHANP。本研究的重点是优化在不同负荷条件下IBU分子向MHANP的掺入。合成的MHANP和IBU-MHA颗粒通过X射线衍射(XRD),傅立叶变换红外光谱(FTIR),布鲁诺拉·埃梅塔·泰勒(BET),透射电子显微镜(TEM)和热分析( TGA)。通过紫外-可见(UV-Vis)光谱法测定了IBU-MHA颗粒的载药量(DL)效率,结果表明,以IBU / MHANPs比可获得具有高DL(34.5%)的优化IBU-MHA颗粒用乙醇作为溶剂,其粘度为35/50(mg / mg),浸渍时间为24小时,温度为40℃。进行了体外药物释放测试,以证明IBU-MHA颗粒作为持续药物输送系统的效率。对于该颗粒观察到更持续和受控的药物释放,表明其作为局部药物释放的药物储库可能具有良好的潜力。 ??

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号